Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

This study is currently recruiting participants.

Verified April 2013 by Dana-Farber Cancer Institute

Study NCT01484314 Information provided by Dana-Farber Cancer Institute

First Received on November 30, 2011. Last Updated on April 25, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Thrombocytopenia
Multiple Myeloma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Eltrombopag

Sponsors listed in this trial